Can Inovio Pharmaceuticals Inc(INO), Advaxis, Inc.(ADXS) and Microvision, Inc.(MVIS) All Live Up To Their Current Potential?

Posted by admin March 17, 2015 0 Comment 1020 views

New York, NY – GDP INSIDER  –  03/17/2015.

This article discusses three companies: Inovio Pharmaceuticals Inc(NASDAQ:INO), Advaxis, Inc.(NASDAQ:ADXS) and Microvision, Inc.(NASDAQ:MVIS)

Inovio Pharmaceuticals Inc(NASDAQ:INO) saw solid gains yesterday with the stock soaring 19.60% or $1.38 to close at $8.42 on very high trading volume of 4.92 million shares compared to its 30-day average trading volume of 0.660 million following the announcement of its fourth quarter financial results. On March 13th, analysts at HC Wainright initiated ‘buy’ coverage on the stock and set their price target at $17. The US-based clinical-stage biopharmaceutical company has been climbing steadily since the beginning of this month and is now up 24.01% compared to the S&P 500, which has declined 0.91% since the beginning of March. With one year target estimate of $21.40 and RSI of 63.57 there is plenty of upside, making Inovio Pharmaceuticals Inc a good hold and potential buy.

Can Inovio Pharmaceuticals Inc Fuel A Rally In Its Stock? Read Our Free INO Analysis Here.

Advaxis, Inc.(NASDAQ:ADXS) also saw solid gains yesterday with the stock closing up 4.83% or sixty cents to close at $13.01, after hitting a new one year high of $14.50 during the day on very heavy trading of 3.73 million shares compared to its 30-day average trading volume of 0.890 million. Over the past one week and over the past one month, the shares of US-based clinical-stage biopharmaceutical company has gained 1.56% and 82.72% respectively. The RSI of 65.66 indicates that the stock is not overvalued, the MFI of 77 shows that the money is flowing in the right direction and still has the room to improve. Not only that, but the stock is currently holding 35.84% above its 50-day moving average of $9.68 and 163.96% above its 200-day moving average of $4.98, making it a buy.

Can Advaxis, Inc Put Upward Pressure On Its Value In Near Future? Take A Closer Look At The Company With Our Free ADXS Analysis.

Microvision, Inc.(NASDAQ:MVIS) gained forty cents to move to a closing price of $3.14. Thanks to its 14.60% boost in value, the US-based high-resolution miniature laser display developer also recorded a new one year high of $3.44. Despite the recovery that Microvision, Inc has enjoyed yesterday, the company figures remain significantly below the $28 closing prices recorded during the 2010 calendar year. The spike in value came as a result of a high trading volume of 13.22 million, compared to its 30-day average trading volume of 0.467 million. The stock has been doing well recently, gaining 53.92% over the last one year compared to S&P 500’s gain of 11.96% over the same period, making it a good stock to buy.

Will Microvision, Inc Continue To Outperform In Future? Learn More About Company’s Trajectory With Our Free MVIS Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment